Structural analysis of human liver glyceraldehyde-3-phosphate dehydrogenase - PubMed (original) (raw)

Comparative Study

. 2005 Nov;61(Pt 11):1508-13.

doi: 10.1107/S0907444905026740. Epub 2005 Oct 19.

Affiliations

• PMID: 16239728
• DOI: 10.1107/S0907444905026740

Comparative Study

Structural analysis of human liver glyceraldehyde-3-phosphate dehydrogenase

S A Ismail et al. Acta Crystallogr D Biol Crystallogr. 2005 Nov.

Abstract

The crystal structure of human liver glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has been determined. This structure represents the first moderate-resolution (2.5 A) and crystallographically refined (Rfree = 22.9%) human GAPDH structure. The liver GAPDH structure consists of a homotetramer, each subunit of which is bound to a nicotinamide adenine dinucleotide (NAD+) molecule. The GAPDH enzyme has glycolytic and non-glycolytic functions, both of which are of chemotherapeutic interest. The availability of a high-quality human GAPDH structure is a necessity for structure-based drug design. In this study, structural differences between human liver and skeletal muscle GAPDHs are reported in order to understand how these two enzymes might respond to anti-trypanosomatid GAPDH inhibitors.

PubMed Disclaimer

Similar articles

• Conformational changes in Leishmania mexicana glyceraldehyde-3-phosphate dehydrogenase induced by designed inhibitors.
  Suresh S, Bressi JC, Kennedy KJ, Verlinde CL, Gelb MH, Hol WG. Suresh S, et al. J Mol Biol. 2001 Jun 1;309(2):423-35. doi: 10.1006/jmbi.2001.4588. J Mol Biol. 2001. PMID: 11371162
• Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design.
  Aronov AM, Verlinde CL, Hol WG, Gelb MH. Aronov AM, et al. J Med Chem. 1998 Nov 19;41(24):4790-9. doi: 10.1021/jm9802620. J Med Chem. 1998. PMID: 9822549
• Structural basis for selective inhibition of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase: molecular docking and 3D QSAR studies.
  Guido RV, Oliva G, Montanari CA, Andricopulo AD. Guido RV, et al. J Chem Inf Model. 2008 Apr;48(4):918-29. doi: 10.1021/ci700453j. Epub 2008 Feb 28. J Chem Inf Model. 2008. PMID: 18303835
• The rational design of trypanocidal drugs: selective inhibition of the glyceraldehyde-3-phosphate dehydrogenase in Trypanosomatidae.
  Callens M, Hannaert V. Callens M, et al. Ann Trop Med Parasitol. 1995 Dec;89 Suppl 1:23-30. doi: 10.1080/00034983.1995.11813011. Ann Trop Med Parasitol. 1995. PMID: 8745924 Review.

Cited by

• Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration.
  Butterfield DA, Hardas SS, Lange ML. Butterfield DA, et al. J Alzheimers Dis. 2010;20(2):369-93. doi: 10.3233/JAD-2010-1375. J Alzheimers Dis. 2010. PMID: 20164570 Free PMC article. Review.
• The Antimicrobials Anacardic Acid and Curcumin Are Not-Competitive Inhibitors of Gram-Positive Bacterial Pathogenic Glyceraldehyde-3-Phosphate Dehydrogenase by a Mechanism Unrelated to Human C5a Anaphylatoxin Binding.
  Gómez S, Querol-García J, Sánchez-Barrón G, Subias M, González-Alsina À, Franco-Hidalgo V, Albertí S, Rodríguez de Córdoba S, Fernández FJ, Vega MC. Gómez S, et al. Front Microbiol. 2019 Feb 26;10:326. doi: 10.3389/fmicb.2019.00326. eCollection 2019. Front Microbiol. 2019. PMID: 30863383 Free PMC article.
• Biosynthesis of the fungal glyceraldehyde-3-phosphate dehydrogenase inhibitor heptelidic acid and mechanism of self-resistance.
  Yan Y, Zang X, Jamieson CS, Lin HC, Houk KN, Zhou J, Tang Y. Yan Y, et al. Chem Sci. 2020 Aug 19;11(35):9554-9562. doi: 10.1039/d0sc03805a. Chem Sci. 2020. PMID: 34094220 Free PMC article.
• Structure of insoluble rat sperm glyceraldehyde-3-phosphate dehydrogenase (GAPDH) via heterotetramer formation with Escherichia coli GAPDH reveals target for contraceptive design.
  Frayne J, Taylor A, Cameron G, Hadfield AT. Frayne J, et al. J Biol Chem. 2009 Aug 21;284(34):22703-12. doi: 10.1074/jbc.M109.004648. Epub 2009 Jun 19. J Biol Chem. 2009. PMID: 19542219 Free PMC article.
• Plant cytoplasmic GAPDH: redox post-translational modifications and moonlighting properties.
  Zaffagnini M, Fermani S, Costa A, Lemaire SD, Trost P. Zaffagnini M, et al. Front Plant Sci. 2013 Nov 12;4:450. doi: 10.3389/fpls.2013.00450. eCollection 2013. Front Plant Sci. 2013. PMID: 24282406 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • International Union of Crystallography

• Molecular Biology Databases

  • GlyGen glycoinformatics resource

• Research Materials

  • NCI CPTC Antibody Characterization Program